Skip to main content
MBBC
NASDAQ Finance

Marathon Bancorp Seeks Shareholder Approval for New Equity Plan Authorizing 8% Potential Dilution

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
7
Price
$14.27
Mkt Cap
$41.934M
52W Low
$9.9
52W High
$14.64
Market data snapshot near publication time

summarizeSummary

Marathon Bancorp filed a definitive proxy statement for a special meeting to approve a new 2026 Equity Incentive Plan, which could result in approximately 8% potential dilution if all authorized shares are issued.


check_boxKey Events

  • Shareholder Meeting Scheduled for Equity Plan Approval

    A Special Meeting of Stockholders is scheduled for May 28, 2026, to vote on the approval of the Marathon Bancorp, Inc. 2026 Equity Incentive Plan.

  • New Equity Plan Authorizes Significant Share Issuance

    The proposed 2026 Equity Incentive Plan authorizes the issuance of up to 237,077 shares of common stock, comprising 169,341 shares for stock options and 67,736 shares for restricted stock awards or units.

  • Potential Dilution of Approximately 8%

    Based on 2,950,136 shares outstanding as of April 10, 2026, the full issuance of shares under the new plan would represent a potential dilution of approximately 8.03%.

  • Replaces Exhausted Prior Plan

    The new plan is necessary as the 2022 Equity Incentive Plan has no shares remaining for issuance, highlighting the company's need for ongoing equity compensation tools.


auto_awesomeAnalysis

Marathon Bancorp has filed a definitive proxy statement for a special meeting to approve its 2026 Equity Incentive Plan. This plan is crucial as the previous 2022 Equity Incentive Plan has no shares remaining for issuance, making the new plan essential for the company's ability to attract, retain, and incentivize employees and directors. If fully utilized, the plan could result in a potential dilution of approximately 8% of the current outstanding shares. While equity incentive plans are a standard compensation tool, this level of potential dilution is notable. The proposal comes as the company is trading near its 52-week high, following a period of strong net income growth and loan portfolio expansion, which may make the dilutive aspect more acceptable to shareholders given the positive operational context.

At the time of this filing, MBBC was trading at $14.27 on NASDAQ in the Finance sector, with a market capitalization of approximately $41.9M. The 52-week trading range was $9.90 to $14.64. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed MBBC - Latest Insights

MBBC
Apr 24, 2026, 9:01 AM EDT
Filing Type: 8-K
Importance Score:
8
MBBC
Apr 24, 2026, 8:00 AM EDT
Filing Type: DEF 14A
Importance Score:
7
MBBC
Feb 11, 2026, 7:30 AM EST
Filing Type: 10-Q
Importance Score:
8